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limb complications
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Objective: Aortoiliac tortuosity is often cited subjectively as a causative factor in iliac limb complications after endovascular
aneurysm repair (EVAR); however, evidence on this subject is poor. The aim of this study was to investigate the impact of
stent grafting on aortoiliac tortuosity and to explore the role of the tortuosity index (TI) as a predictor of iliac limb
complications after EVAR.
Methods: A retrospective case-control study was performed comparing an iliac limb complication group with a control
group. Reconstructed computed tomography angiography images were analyzed to calculate TI of the aortoiliac
segments.
Results: This study included 153 patients, 120 in the control groups (40 Zenith ﬂex [Cook Medical, Bloomington, Ind],
40 Endurant II [Medtronic, Minneapolis, Minn], and 40 Excluder [W. L. Gore and Associates, Flagstaff, Ariz] stent
grafts) and 33 in the complications group (13 Zenith ﬂex, 14 Endurant II, 4 Excluder, and 2 Aorﬁx [Lombard Medical,
Oxfordshire, UK] stent grafts). There was a signiﬁcant reduction in aortic and iliac TI after EVAR. This was greatest with
the Zenith Flex compared with Endurant, with the least change in TI seen after Gore Excluder implantation. Iliac limb
complications included 10 type Ib endoleaks, one iliac limb modular dislocation, two limbs with insufﬁcient engagement,
four occlusions, and 16 iliac limb kinks. There was no signiﬁcant difference in complication rates between the three stent
grafts (Zenith ﬂex, 1.4%; Endurant, 2.9%; Excluder, 1.9%; P [ .115). The median time to iliac complication was 14
months (range, 1-90 months). The iliac limb complication group was found to have a signiﬁcantly increased aortoiliac TI
on both preoperative and postoperative computed tomography imaging.
Conclusions: EVAR has a signiﬁcant effect on aortoiliac tortuosity. Despite the reduction of aortoiliac tortuosity after the
insertion of a stent graft, TI may serve as a predictor of iliac limb complications after EVAR. (J Vasc Surg 2014;60:585-9.)Aortoiliac tortuosity is often used subjectively as a po-
tential barrier to endovascular repair of an aortic aneurysm
(EVAR). The degree of tortuosity is, in many cases,
described qualitatively with respect to iliac anatomy causing
technical difﬁculties with stent graft placement.1-3 These
complications include arterial dissection, rupture, and fail-
ure of progression of the stent graft delivery system
through the iliac artery to allow positioning in the infrare-
nal aortic segment.4-6 The use of aortoiliac tortuosity as a
marker for postimplantation complications is less well un-
derstood. Despite the use of aortoiliac tortuosity in the
report of Chaikof et al on the standardized reporting prac-
tices in vascular surgery for the Society of Vascular Surgery,
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ments in their instructions for use (IFU), instead quoting
discrete aortic and iliac artery angles as potential barriers
to implantation.7-9
Limb complications after EVAR include kinking, oc-
clusion, type Ib endoleak, and limb dislocation and are
an important contributor to postimplantation stent graft
complications.10-12 Iliac artery diameter, graft “kinking,”
and extension into the external iliac artery have been found
to be risk factors for iliac limb complications, but no prior
assessment of tortuosity and iliac limb complications has
been performed.
In this study, we aimed to evaluate the impact of
infrarenal EVAR on aortoiliac tortuosity and to assess the
impact of aortoiliac tortuosity on iliac limb complications
after endovascular repair.
METHODS
A retrospective observational study was performed
comparing a control group with an iliac complication
group. Groups were identiﬁed from the in-house master
database, listing all aortic stent grafts inserted in our tertiary
referral unit since May 2006. Inclusion criteria for this
study were the insertion of an infrarenal bifurcated stent
graft, with the iliac stent graft limbs being deployed in
the common iliac arteries. Extensions into the external iliac
arteries, fenestrated devices, branched devices, and other585
Table I. Demographic and morphologic data
Control group Iliac complication group P value
Number 120 33
Gender, % male 78 76 .956
Age, years 76 (59-90) 75 (37-91) .779
AAA size, mm 63 (54-100) 69 (55-100) .024a
Zenith 64 (54-94)
Endurant 63 (55-100) P ¼ .448
Excluder 66 (55-89)
Iliac length 61 (14-100) 57 (19-103) .089
Iliac limb diameter, mm 15.5 (9-27) 16.2 (10-26) .117
Follow up, months 36 (1-72) 14 (1-90) .006a
AAA, Abdominal aortic aneurysm.
Data are presented as median (range).
at-test.
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procedures were undertaken at primary stenting. To allow
data analysis, only patients who had accessible preoperative
computed tomography angiography (CTA) and postoper-
ative CTA images within our unit were included.
Postoperative follow-up protocol involves 1-month
CTA along with plain abdominal radiography in two pro-
jections and a duplex ultrasound scan. Further annualized
follow-up is in the form of plain radiography and duplex ul-
trasonography. Software used for imaging analysis was the
Centricity image viewing systems (GE Healthcare, Little
Chalfont, UK) and the Siemens Leonardo three-
dimensional CT reconstruction software (Siemens,
Munich, Germany).
Control group. The control group was made up of
120 patients (240 iliac limbs) consisting of 40 consecutive
patients in three groups according to the major EVAR
stent grafts deployed in this unit: Zenith Flex (Cook Med-
ical, Bloomington, Ind), Endurant II (Medtronic, Minne-
apolis, Minn), and Excluder (W. L. Gore and Associates,
Flagstaff, Ariz). This group was identiﬁed from the in-
house master database of all EVARs performed in our unit.
Iliac complication group. This group was also identi-
ﬁed from the in-house database and consisted of all patients
who had a complication or a secondary intervention to the
iliac portion of their endovascular stent graft. All in-
terventions, including iliac limb extension, angioplasty,
relining, and placement of bare metal stent for kinking
(deﬁned by a doubling of peak systolic velocity throughout
the limb and conﬁrmed with subsequent pressure mea-
surement on angiography) and occlusion, were used in the
analysis. Patients who developed a kink (following these
criteria) were treated pre-emptively endovascularly with the
placement of a bare metal stent. In all cases, this reduced
the pressure measurement and subsequent peak systolic
velocities recorded on duplex follow-up. Insufﬁcient
engagement was deﬁned by iliac stent engagement within
the common iliac artery less than the manufacturer’s IFU.
The percentage iliac limb complication rates of different
stent grafts was calculated by the total number of standard
stent grafts from the master in-house database.Data analysis. Demographic information was gath-
ered on the patients and compared by comparison statistics.
Tortuosity index (TI) was calculated with the method
described by Chaikof et al.13 TI was deﬁned as the dis-
tance along the central lumen line divided by the straight-
line distance between two set points. This was performed
for aortic tortuosity from the lowest renal to the aortic
bifurcation and for iliac tortuosity from the aortic bifurca-
tion to the bifurcation of the common iliac artery. Mea-
surements were performed on three-dimensional
reconstructions of the preoperative and postoperative CTA
scans (in the anteroposterior plane).
Statistical analysis was carried out with SPSS version
17.0 software (SPSS Inc, Chicago, Ill). Comparisons
between groups were made by the t-test (gaussian popula-
tions) or the Mann-Whitney U, Wilcoxon, and Kruskal-
Wallis tests (non-gaussian) for continuous variables and
the c2 test for categorical variables, as appropriate.
P values < .05 were considered signiﬁcant. TI measure-
ments were performed by two authors, and because of
this being a continuous variable, intraclass correlation was
calculated over a random sample (intraclass correlation
coefﬁcient ¼ 0.8912; 95% conﬁdence interval [CI],
0.8089-0.9381). This illustrates a strong agreement be-
tween researchers. Analysis of skewness and kurtosis illus-
trated TI not to be of gaussian distribution.
RESULTS
The control group included 120 patients, and 33 pa-
tients were identiﬁed to form the iliac complication group.
Basic demographics and direct group comparisons are
shown in Table I. Aortic aneurysm size was larger in the
iliac complication group, but there was no difference in
iliac length or diameter between groups. Aortic aneurysm
size in patients allocated to the different stent graft manu-
facturers within the control group was not signiﬁcantly
different.
Impact of EVAR on aortoiliac tortuosity. With use
of the whole study cohort (both the control and the iliac
intervention groups), TI was calculated before and after
EVAR. Left iliac artery tortuosity was greater than right,
Table II. Tortuosity related to graft device implanted
Zenith
(n ¼ 40)
Excluder
(n ¼ 40)
Endurant
(n ¼ 40)
Preoperative TI
P valuea
Preoperative
Aortic 1.08 (1.01-1.48) 1.09 (1.01-1.38) 1.12 (1.01-1.54) .062
Right iliac 1.11 (1.02-1.35) 1.11 (1.01-1.51) 1.11 (1.02-1.35) .659
Left iliac 1.13 (1.01-1.51) 1.14 (1.02-1.41) 1.16 (1.00-1.61) .246
Postoperative
Aortic 1.04 (1.00-1.40) 1.07 (1.01-1.31) 1.10 (1.01-1.48) NA
Right iliac 1.07 (1.01-1.31) 1.10 (1.01-1.48) 1.09 (1.01-1.31) NA
Left iliac 1.09 (1.01-1.39) 1.13 (1.01-1.40) 1.14 (1.02-1.58) NA
NA, Not applicable; TI, tortuosity index.
Data are presented as median (range).
aKruskal-Wallis test.
Table III. Iliac complications by stent graft manufacturer
Zenith Endurant Excluder Aorﬁx
Total implanted, No. (iliac limbs) 453 (906) 244 (488) 106 (212) 2 (4)
Iliac limb complications, No. (%) 13 (1.4) 14 (2.9) 4 (1.9) 2 (50.0)
P ¼ .115a
Complications
Kink 5 8 2 1
Occlusion 2 2 d d
Insufﬁcient engagement 1 d 1 d
Dislocation 1 d d d
Ib endoleak 4 4 1 1
ac2 test.
Table IV. The inﬂuence of tortuosity index (TI) on iliac
limb complications
Control
(n ¼ 240 limbs)
Iliac complication group
(n ¼ 33 limbs) P valuea
Preoperative
Aortic 1.10 (1.01-1.54) 1.16 (1.02-1.54) .0001
Right iliac 1.11 (1.01-1.51) 1.18 (1.03-1.41) .002
Left iliac 1.14 (1.05-1.62) 1.23 (1.05-1.62) .002
Postoperative
Aortic 1.07 (1.00-1.48) 1.14 (1.00-1.48) .0001
Right iliac 1.08 (1.01-1.48) 1.15 (1.01-1.54) .043
Left iliac 1.12 (1.01-1.58) 1.18 (1.02-1.55) .001
Data are presented as median (range).
aMann-Whitney U test (unpaired comparison).
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range, 1.01-1.52; left: median, 1.14; range, 1.00-1.61; P ¼
.892). There was a highly signiﬁcant reduction in tortuosity
after EVAR. This was consistent in both the aortic and iliac
segments (aortic: median, 1.11 [range, 1.01-1.54] to 1.09
[range, 1.00-1.48]; P < .0001; right iliac: median, 1.12
[range, 1.01-1.57] to 1.10 [range, 1.01-1.54]; P < .0001;
left iliac: median, 1.16 [range, 1.00-1.62] to 1.31 [range,
1.01-1.58]; P < .001).
There was no signiﬁcant difference in the preoperative
TI between the three graft manufacturers used in the
study. After EVAR, reduction in TI was seen with all three
graft types, and the change in TI from preoperative to post-
operative was used to compare manufacturers. The greatest
reduction in tortuosity was seen after implantation of the
Zenith stent graft, followed by the Endurant stent graft.
The lowest reduction in tortuosity after EVAR was seen
with the implantation of the Excluder stent graft (median
[range] change in TI: Zenith, 0.04 [0.01-0.3]; Endurant,
0.02 [0-0.25]; Excluder, 0.02 [0.02-0.09]; P < .001).
Table II illustrates the preoperative and postoperative TI
according to stent graft manufacturer.
Impact of tortuosity on iliac complications. There
were 33 patients identiﬁed with iliac complications: 10
type Ib endoleaks, one iliac limb modular dislocation,two with insufﬁcient engagement with concern for immi-
nent type Ib or disengagement, four occlusions, and 16
iliac limb kinks. Table III shows the distribution of com-
plications between the different stent grafts along with the
overall rates of iliac limb complications. Because of the
small number of Aorﬁx (Lombard Medical, Oxfordshire,
UK) grafts implanted in this unit, these grafts were
excluded from inter-manufacturer analysis. The median
time to iliac complication was 14 months (range, 1-90
JOURNAL OF VASCULAR SURGERY
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iliac limb complications between the three main grafts
implanted.
Increased aortoiliac tortuosity resulted in an increased
iliac complication rate. Table IV illustrates preoperative
and postoperative TI in the two groups. A signiﬁcantly
increased TI was found to be associated with iliac compli-
cation in both the aortic and iliac segments. This ﬁnding
was present preoperatively and persisted after the implanta-
tion of a stent graft.
DISCUSSION
The success of EVAR is dependent on aortoiliac
morphology. The IFU provided from the stent graft man-
ufacturers give a set of guidelines in which positive
outcomes from EVAR should be expected. The use of
high-resolution CTA scanning gives us an opportunity to
study this morphology and the impact of EVAR on this
morphology.14-16 Rather than isolated angulation, TI
allows an overall assessment of the curvature and asym-
metric nature of the aortoiliac morphology. The central
lumen line and tortuosity measurements have been used
in only a small number of research studies, looking at
both preoperative assessment and outcomes after EVAR,
generally correlating with qualitative data, in which more
tortuous morphology corresponds to a poorer
outcome.13,17-21 This view is not universal, and Wolf
et al,1 in a smaller noncontrolled series, found that TI
correlated with increased complexity of repair but not
with intermediate-term results. We demonstrated a strong
correlation between iliac limb complications and tortuosity
after EVAR. This ﬁnding was valid for both the aortic and
iliac segments. Chaikof et al13 classiﬁed an iliac TI of >1.6
as severe (within a multifactorial preoperative scoring sys-
tem). Although the TI calculated in the majority of our
iliac segments fell below this level, there was still signiﬁcant
variation resulting in differences with respect to iliac limb
outcomes.
There was a signiﬁcant reduction in TI after EVAR,
and this varied by the stent graft used. This illustrates a
variation in the conformability or relative “stiffness” of
the different stent grafts due to the differences in stent graft
design and manufacture.22,23 In this series, however, this
variation in stent graft conformability did not correlate
with a difference in the number of iliac limb complications.
Although ﬁrst-generation stent graft analysis regarding
EVAR complications is commonplace and illustrates varia-
tion in stent graft behavior, analysis of the latest wave of
grafts is not yet forthcoming and is likely to be more difﬁ-
cult to interpret, given the trend toward a reduction in
complications with newer stent grafts.24,25 The variation
in the change in TI found after implantation of different
stent grafts requires further study, and its impact on non-
iliac-limb complications after EVAR would be interesting.
The addition of a tortuosity measurement to the stent graft
IFU is food for thought, but it would be beyond the scope
of this study to suggest a TI cutoff, given that complica-
tions after EVAR are likely to be multifactorial. It is likelythat tortuosity is one of a number of factors (including
calciﬁcation, proximal and distal landing zones, speciﬁc
areas of angulation, thrombus load) that inﬂuence the suc-
cess of EVAR.
The analysis performed has limitations with respect
to its retrospective nature and selectivity. The small
numbers and heterogeneity of iliac complications, although
corresponding to published series, preclude subgroup anal-
ysis.10,24 Despite the positive ﬁnding of the inﬂuence of TI
in iliac limb complications, there is likely to be different
multifactorial elements, depending on the type of iliac
limb complications. Factors including iliac artery enlarge-
ment, aortic sac size, and change in sac size may have
more of an effect on type Ib endoleaks (for example)
than iliac kinking or occlusion. The data do, however, illus-
trate the use of TI as an indicator of iliac limb complica-
tions, and this is a signiﬁcant novel ﬁnding. This is a
large case-control series examining both aortoiliac tortuos-
ity as a result of EVAR and its signiﬁcance in iliac compli-
cations. Further work in this area should look at TI along
with other morphologic features of both iliac and aortic ar-
teries, such as thrombus load, calciﬁcation, suprarenal neck
angulation, length of iliac arteries, and subsequent iliac
limb ﬁxation, to assess the relative importance of these fea-
tures. This is a difﬁcult task, however, because of the sub-
jective nature of reporting of many of these features. The
improvement of computer modeling and CTA analysis
may improve the accuracy of the reporting of these
features.
CONCLUSIONS
We have identiﬁed a signiﬁcant change in the tortuosity
of the aortoiliac segments after EVAR and its variation ac-
cording to the different stent grafts. In addition, we have
identiﬁed TI as an indicator for iliac complications after
EVAR, and this information may be useful in preoperative
assessment and outcome prediction. This effect is main-
tained despite the reduction in tortuosity after stent graft
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